13 employees
Tosk is a biopharmaceutical company dedicated to improving the safety of drugs for diseases such as cancer, arthritis, and psoriasis.
2008
$2M
from 1 investors over 1 rounds
Tosk, Inc. raised $2M on February 14, 2018
Investors: National Cancer Institute